Clinical Trial: Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07473128) titled 'Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer' on March 05.

Brief Summary: The goal of this clinical trial is to compare the efficacy and safety of trilaciclib versus placebo in subjects with limited stage small cell lung cancer. The main question it aims to answer is:

Does trilaciclib have a myeloprotective effect in subject with limited stage small cell lung cancer?

Participants will be randomised to receive either trilaciclib or placebo.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Limited Stage Small Cell Lung Cancer

Intervention: DRU...